FIELD: medicine, pharmaceutics.
SUBSTANCE: pharmaceutical composition, which has anti-viral activity against hepatitis C, includes solid suspension, obtained by extrusion of melt of hydrochloride (2R,3S,4R,5R)-5-(4-amino-2-oxo-2H-pyrimidine-1-yl)-2-azido-3,4-bis-isobutiryoxytetrahydrofuran-2-ylmethyl ether of isobutyric acid (I) and block-copolymer polyethyleneglycol (PEG)/polypropylenglycol (PPG). Preferably block-copolymer PEG/PPG represents poloxamer 188.
EFFECT: pharmaceutical composition has improved speed of dissolution and bio-availability.
14 cl, 2 ex
Title |
Year |
Author |
Number |
NEW DOSAGE FORM |
2006 |
- Akhmed Khasim
- Pehjdzh Zuzanna
- Shakh Navnit Khargovindas
|
RU2431473C2 |
SOLID DOSED OUT FORMS INCLUDING FIBRAT AND STATIN |
2004 |
|
RU2343905C2 |
PHARMACEUTICAL COMPOSITION CONTAINING PYRIMIDIN -A-ONE DERIVATIVE, COVERED WITH INTESTINE-SOLUBLE POLYMER |
2004 |
- Van Shi Dirk Marinus Jokhannes
|
RU2359660C2 |
COMPOSITION CONTAINING SOLID DISPERSION OF BAZEDOXIFENE ACETATE |
2005 |
- Shakh Sied M.
- Ali Kadum A.
- Ofslager Kristian L.
- Favzi Makhdi B.
|
RU2400227C2 |
PERORAL COMPOSITIONS CONTAINING ESTER 17- HYDROXYPROHESTERON, AND CORRESPONDING METHODS |
2012 |
- Giliyar Chandrashekar
- Venkateshvaran Srinivansan
- Chikmas Basavaraj
- Nachaegari Satish Kumar
- Nachiappan Chidambaram
- Patel Makhesh V.
|
RU2640912C2 |
PHARMACEUTICAL COMPOSITION |
2008 |
- Kodzima Masazumi
- Kuno Josio
- Nakagami Khiroaki
- Sagasaki Sindzi
- Isidokh Koiti
- Sekiguti Gaku
|
RU2470637C2 |
PHARMACEUTICAL COMBINATION, COMPOSITION, AND COMBINED COMPOSITION CONTAINING GLUCOKINASE ACTIVATOR AND BIGUANIDE HYPOGLYCEMIC DRUG, AS WELL AS THEIR PREPARATION METHOD, AND THEIR USE |
2019 |
- Chen, Li
- Li, Yongguo
- Wang, Gaosen
|
RU2780377C2 |
PHARMACEUTICAL COMBINATION, COMPOSITION, AND COMBINED COMPOSITION, CONTAINING GLUCOKINASE ACTIVATOR AND PPAR RECEPTOR ACTIVATOR, AND THEIR PREPARATION METHOD, AND THEIR USE |
2019 |
- Chen, Li
- Li, Yongguo
- Wang, Gaosen
- Gao, Huisheng
|
RU2781638C2 |
PHARMACEUTICAL COMBINATION, COMPOSITION AND COMPOUND, CONTAINING A GLUCOKINASE ACTIVATOR AND AN ALPHA-GLUCOSIDASE INHIBITOR, METHODS FOR PRODUCTION AND APPLICATION THEREOF |
2019 |
- Chen, Li
- Li, Yongguo
- Wang, Gaosen
- Gao, Huisheng
|
RU2775603C2 |
PHARMACEUTICAL COMBINATION, COMPOSITION, AND COMBINED FORMULATION CONTAINING A GLUCOKINASE ACTIVATOR AND A KATP CHANNEL BLOCKER, METHOD FOR PRODUCTION AND APPLICATION THEREOF |
2019 |
- Chen, Li
- Li, Yungo
- Van, Gaosen
- Gao, Khuejshen
|
RU2772875C1 |